Glucosamine and chondroitin use and mortality among adults in the United States from 1999 to 2014 Journal Article
| Authors: | Bhimani, J.; O'Connell, K.; Kuk, D.; Du, M.; Navarro, S. L.; Kantor, E. D. |
| Article Title: | Glucosamine and chondroitin use and mortality among adults in the United States from 1999 to 2014 |
| Abstract: | Introduction: Glucosamine and chondroitin are supplements that are often, but not always, used in combination for arthritis and joint pain. Multiple studies have suggested that glucosamine and chondroitin may be associated with reduced risk of several diseases, as well as all-cause, cancer- and respiratory disease-specific mortality.Methods: Nationally representative data from the National Health and Nutrition Examination Survey (NHANES) were used to further evaluate the association between glucosamine and chondroitin with mortality. Participants include 38,021 adults, ages 20+ years and older, who completed the detailed NHANES between 1999 and 2014. Participants were followed for death through linkage with the National Death Index through the end of 2015, over which time 4905 deaths occurred. Adjusted hazard ratios (HRs) for overall and cause-specific mortality were estimated using Cox regression models.Results: Despite glucosamine and chondroitin use appearing to be inversely associated with mortality in the minimally adjusted models, no association was observed in multivariable models (glucosamine: HR = 1.02; 95% confidence interval [CI]: 0.86-1.21, chondroitin: HR = 1.04, 95% CI: 0.87-1.25). No association with cancer mortality or other mortality rate was observed after multivariable adjustment. There was a suggestive, nonsignificant inverse association for cardiovascular-specific mortality (glucosamine HR = 0.72; 95% CI: 0.46-1.15, chondroitin: HR = 0.76; 95% CI: 0.47-1.21).Conclusion: The lack of significant relationship between glucosamine and chondroitin use and all-cause or cause-specific mortality after adjusting extensively for multiple covariates in this nationally representative adult population was in contrast to prior literature. Given the limited power to explore the cause-specific mortality, future well-powered studies will be needed to better understand the potential association with cardiovascular-specific mortality. |
| Keywords: | mortality; cancer risk; inflammation; protein; knee osteoarthritis; activation; all-cause mortality; myocardial-infarction; cohort; nonsteroidal antiinflammatory drugs; associations; glucosamine; chondroitin; dietary-supplements; c-reactive |
| Journal Title: | Journal of Integrative and Complementary Medicine |
| Volume: | 29 |
| Issue: | 8 |
| ISSN: | 2768-3605 |
| Publisher: | Mary Ann Liebert, Inc. |
| Date Published: | 2023-08-01 |
| Start Page: | 492 |
| End Page: | 500 |
| Language: | English |
| ACCESSION: | WOS:000956726600001 |
| DOI: | 10.1089/jicm.2022.0783 |
| PROVIDER: | wos |
| PMCID: | PMC10457612 |
| PUBMED: | 36971848 |
| Notes: | Article -- MSK Cancer Center Support Grant (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Elizabeth Kantor -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work